The global Orthobiologics Market is anticipated to witness considerable growth with the rising number of cases regarding sports injuries and road accidents. Fortune Business Insights published the information in a recent report, titled “Orthobiologics Market” Size, Share and Global Trend by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics) and Geography Forecast till 2026” which predicts the global market to expand at a CAGR of 4.5% in the forecast years. As per the report, the global market was worth US$ 5830.1 Mn in the year 2017 and is estimated to reach a value of US$ 8261.6 Mn by 2026.
Request For Sample PDF@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthobiologics-market-100173
Key Companies Covered in The Report
- Zimmer Biomet
- Genzyme Corporation (Sanofi)
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Stryker
- Medtronic
- Wright Medical Group N.V.
- Anika Therapeutics, Inc.
- SeaSpine
- Bioventus
- RTI Surgical Holdings, Inc.
- Musculoskeletal Transplant Foundation
- Other players
North America Emerges as Most Lucrative Region Owing to Rising Cases of Obesity
In 2018, the market in North America was valued at US$ 2326.2 Mn. Fortune Business Insights predicts North America to continue leading the market through the forecast period. This region has the most favourable reimbursement policies, which drives the market. Furthermore, the region has witnessed a considerable rise in the number of obese people over the years, which in turn, will result in the increasing number of orthopaedic surgeries among outpatients. Also, companies in the U.S. are adopting business strategies to increase the market share, which is expected to boost the market in North America. Trailing North America, Europe is the second-leading region covering a substantial share in the global market. This is ascribable to a recent approval of viscosupplements called Cingal in Europe. The market in Asia Pacific is also expected to offer growth opportunities mainly on account of rising demand for viscosupplements especially in India.
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/orthobiologics-market-100173
Table of Content:
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Prevalence of Soft Tissue Injuries – For Key Countries, 2018
- Regulatory Scenario – For Key Countries
- Number of Spinal Fusion Surgrey – For Key Countries, 2018
- New Product Launch
- Key Industry Developments -Mergers, Acquisitions and Partnerships
- Global Orthobiologics Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Viscosupplements
- Bone Growth Stimulators
- Bone Morphogenetic Proteins (BMP)
- Platelet-Derived Growth Factors
- Demineralized Bone Matrix (DBM)
- Synthetic Bone Substitutes
- Stem Cells
- Allografts
- Others
- Market Analysis, Insights and Forecast – By Application
- Spinal Fusion
- Maxcillofacial & Dental
- Soft Tissue Repair
- Reconstructive & Fracture Surgery
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Competitive Analysis
- Strategic Recommendations
Continued…
Post-surgery Complications to Restrict the Growth by 2026
Mounting cost associated with orthobiologic procedures is expected to affect the market’s growth in the coming years. Moreover, post-surgery hitches witnessed by some of the orthobiology surgical centers may impede the growth and hamper the usage of orthobiologics. Also, strict regulatory approvals for orthobiologics and less number of clinical trials are some other factors that may pose a serious threat to the Orthobiologics Market.
Bioventus Develops Next-Generation Orthobiological Solution to Treat Chronic Injuries
In 2018, a global leader of orthobiologics solutions – Bioventus signed an agreement with a division of LifeLink Foundation Inc. called LifeLink Tissue Bank last year. The aim was to develop a next-generation bone allograft orthobiologic solution for patients suffering from trauma or spine injuries. Companies have also received FDA approvals for the treatment of spine injuries. For instance, Medtronic recently launched a protein called Infuse Bone Morphogenetic which is used for diagnosing spine surgeries. In addition to this, the company is expected to hold the majority of share in the global Orthobiologics Market. Some of the other leading players in the global market are Stryker, Sea Spine, Zimmer Biomet, Bioventus, RTI Surgical Holdings, Inc., DePuy Synthes (Johnson & Johnson Services, Inc.), Wright Medical Group N.V.
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/orthobiologics-market-100173
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com